A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions

International Journal of Developmental Neuroscience

Volumn 27, Issue 4, 2009, Pages 393-398

  Rachidi, Mohammed ^a   Delezoide, Anne Lize ^b   Delabar, Jean Maurice ^a   Lopes, Carmela ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITÉ DE LA POLYNÉSIE FRANÇAISE   (French Polynesia)

Author keywords

Dopey leucine zipper like family; DOPEY2 gene; Down syndrome; Gene expression quantification; Gene overexpression; Mental retardation; Quantitative Assessment of Gene Expression (QAGE); Regionalized gene expression variation; Trisomic human brains; Trisomy 21

Indexed keywords

ARTICLE; BRAIN CORTEX; CEREBELLUM; CHROMOSOME 21; DOPEY2 GENE; DOWN SYNDROME; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATOR GENE; TRANSCRIPTION REGULATION;

BRAIN; CHILD; DOWN SYNDROME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFANT; MENTAL RETARDATION; VESICULAR TRANSPORT PROTEINS;

EID: 67349239989     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2009.02.001     Document Type: Article

References (55)

1. Aylward E.H., Habbak R., Warren A.C., Pulsifer M.B., Barta P.E., Jerram M., and Pearlson G.D. Cerebellar volume in adults with Down syndrome. Arch. Neurol. 54 (1997) 209-212
2. Bahn S., Mimmack M., Ryan M., Caldwell M.A., Jauniaux E., Starkey M., Svendsen C.N., and Emson P. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359 (2002) 310-315
3. Becker L., Mito T., Takashima S., and Onodera K. Growth and development of the brain in Down syndrome. In: Epstein C.H. (Ed). The Morphogenesis of Down Syndrome (1991), Wiley-Liss, New York 133-152
4. Bjorklund M., Taipale M., Varjosalo M., Saharinen J., Lahdenpera J., and Taipale J. Identification of pathways regulation cell size and cell-cycle progression by RNAi. Nature 439 (2006) 1009-1013
5. Carlesimo G.A., Marotta L., and Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35 (1997) 71-79
6. Chrast R., Scott H.S., Papasavvas M.P., Rossier C., Antonarakis E.S., Barras C., Davisson M.T., Schmidt C., Estivill X., Dierssen M., Pritchard M., and Antonarakis S.E. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res. 10 (2000) 2006-2021
7. Coyle J.T., Oster-Granite M.L., and Gearhart J.D. The neurobiologic consequences of Down syndrome. Brain Res. Bull. 16 (1986) 773-787
8. Dahmane N., Charron G., Lopes C., Yaspo M.L., Maunoury C., Decorte L., Sinet P.M., Bloch B., and Delabar J.M. Down syndrome-critical region contains a gene homologous to Drosophila sim expressed during rat and human central nervous system development. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9191-9195
9. Dahmane N., Ghezala G.A., Gosset P., Chamoun Z., Dufresne-Zacharia M.C., Lopes C., Rabatel N., Gassanova-Maugenre S., Chettouh Z., Abramowski V., Fayet E., Yaspo M.L., Korn B., Blouin J.L., Lehrach H., Poutska A., Antonarakis S.E., Sinet P.M., Creau N., and Delabar J.M. Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21 involved in Down syndrome. Genomics 48 (1998) 12-23
10. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 28 (2004) 771-784
11. Dauphinot L., Lyle R., Rivals I., Dang M.T., Moldrich R.X., Golfier G., Ettwiller L., Toyama K., Rossier J., Personnaz L., Antonarakis S.E., Epstein C., Sinet P.M., and Potier M.C. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum. Mol. Genet. 14 (2005) 373-384
12. Delabar J.M., Theophile D., Rahmani Z., Chettouh Z., Blouin J.L., Prieur M., Noel B., and Sinet P.M. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet. 1 (1993) 114-124
13. Drumm J.E., and O'Rahilly R. The assessment of prenatal age from crown to rump length determined ultrasonically. Am. J. Anat. 148 (1977) 555-560
14. Dujon B. The yeast genome project: what did we learn?. Trends Genet. 12 (1996) 263-270
15. Engidawork E., and Lubec G. Molecular changes in fetal Down syndrome brain. J. Neurochem. 84 (2003) 895-904
16. Gillingham A.K., Whyte J.R., Panic B., and Munro S. Mon2, a relative of large Arf exchange factors, recruits Dop1 to the Golgi apparatus. J. Biol. Chem. 281 (2006) 2273-2280
17. Gitton Y., Dahmane N., Baik S., Ruiz I., Altaba A., Neidhardt L., Scholze M., Herrmann B.G., Kahlem P., Benkahla A., Schrinner S., Yildirimman R., Herwig R., Lehrach H., and Yaspo M.L. A gene expression map of human chromosome 21 orthologues in the mouse. Nature 420 (2002) 586-590
18. Golden J.A., and Hyman B.T. Development of the superior temporal neocortex is anomalous in trisomy 21. J. Neuropathol. Exp. Neurol. 53 (1994) 513-552
19. Guipponi M., Brunschwig K., Chamoun Z., Scott H.S., Shibuya K., Kudoh J., Delezoide A.L., El Samadi S., Chettouh Z., Rossier C., Shimizu N., Mueller F., Delabar J.M., and Antonarakis S.E. C21orf5, a novel human chromosome 21 gene, has a Caenorhabditis elegans ortholog (pad-1) required for embryonic patterning. Genomics 68 (2000) 30-40
20. Ito M. The molecular organization of cerebellar long-term depression. Nature Rev. Neurosci. 3 (2002) 896-902
21. Jernigan T.L., Bellugi U., Sowell E., Doherty S., and Hesselink J.R. Cerebral morphologic distinctions between Williams and Down syndromes. Arch. Neurol. 50 (1993) 186-191
22. Kahlem P., Sultan M., Herwig R., Steinfath M., Balzereit D., Eppens B., Saran N.G., Pletcher M.T., South S.T., Stetten G., Lehrach H., Reeves R.H., and Yaspo M.L. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res. 14 (2004) 1258-1267
23. Korenberg J.R., Chen X.N., Schipper R., Sun Z., Gonsky R., Gerwehr S., Carpenter N., Daumer C., Dignan P., Disteche C., Graham Jr. J.M., Hugdins L., McGillivray B., Miyazaki K., Ogasawara N., Park J.P., Pagon R., Pueschel S., Sack G., Say B., Schuffenhauer S., Soukup S., and Yamanaka T. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4997-5001
24. Krasuski J.S., Alexander G.E., Horwitz B., Rapoport S.I., and Schapiro M.B. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am. J. Psychiatry 159 (2002) 74-81
25. Lopes C., Chettouh Z., Delabar J.M., and Rachidi M. The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in mental retardation in Down syndrome and transgenic mice. Biochem. Biophys. Res. Commun. 305 (2003) 915-924
26. Lopes C., Rachidi M., Gassanova S., Sinet P.M., and Delabar J.M. Developmentally regulated expression of mtprd, the murine ortholog of tprd, a gene from the Down syndrome chromosomal region 1. Mech. Dev. 84 (1999) 189-193
27. Lyle R., Gehrig C., Neergaard-Henrichsen C., Deutsch S., and Antonarakis S.E. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res. 14 (2004) 1268-1274
28. Mao R., Wang X., Spitznagel Jr. E.L., Frelin L.P., Ting J.C., Ding H., Kim J.-W., Ruczinski I., Downey T.J., and Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 6 (2005) R107
29. Milner B., Squire L.R., and Kandel E.R. Cognitive neuroscience and the study of memory. Neuron 20 (1998) 445-468
30. Miyashita Y. Cognitive memory: cellular and network machineries and their top-down control. Science 306 (2004) 435-440
31. Nadel L. Down's syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav. 2 (2003) 156-166
32. Pascon R.C., and Miller B.L. Morphogenesis in Aspergillus nidulans requires Dopey (DopA), a member of a novel family of leucine zipper-like proteins conserved from yeast to humans. Mol. Microbiol. 36 (2000) 1250-1264
33. Rachidi M., and Lopes C. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Neurosci. Res. 59 (2007) 349-369
34. Rachidi M., and Lopes C. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur. J. Paediatr. Neurol. 12 (2008) 168-182
35. Rachidi M., Lopes C., Gassanova S., Sinet P.M., Vekemans M., Attie T., Delezoide A.L., and Delabar J.M. Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development. Mech. Dev. 93 (2000) 189-193
36. Rachidi M., Lopes C., Costantine M., and Delabar J.M. C21orf5, a new member of dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in down syndrome. DNA Res. 12 (2005) 203-210
37. Rachidi M., Lopes C., Charron G., Delezoide A.L., Paly E., Bloch B., and Delabar J.M. Spatial and temporal localization during embryonic and fetal human development of the transcription factor SIM2 in brain regions altered in Down syndrome. Int. J. Dev. Neurosci. 23 (2005) 475-484
38. Rachidi M., Lopes C., Vayssettes C., Smith D.J., Rubin E.M., and Delabar J.M. New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1. Biochem. Biophys. Res. Commun. 364 (2007) 488-494
39. Rahmani Z., Blouin J.L., Creau-Goldberg N., Watkins P.C., Mattei J.F., Poissonnier M., Prieur M., Chettouh Z., Nicole A., Aurias A., Sinet P.M., and Delabar J.M. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5958-5962
40. Rahmani Z., Lopes C., Rachidi M., and Delabar J.M. Expression of the mnb (dyrk) protein in adult and embryonic mouse tissues. Biochem. Biophys. Res. Commun. 253 (1998) 514-518
41. Raz N., Torres I.J., Briggs S.D., Spencer W.D., Thornton A.E., Loken W.J., Gunning F.M., McQuain J.D., Driesen N.R., and Acker J.D. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45 (1995) 356-366
42. Reymond A., Marigo V., Yaylaoglu M.B., Leoni A., Ucla C., Scamuffa N., Caccioppoli C., Dermitzakis E.T., Lyle R., Banfi S., Eichele G., Antonarakis S.E., and Ballabio A. Human chromosome 21 gene expression atlas in the mouse. Nature 420 (2002) 582-586
43. Risser D., Lubec G., Cairns N., and Herrera-Marschitz M. Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sci. 60 (1997) 1231-1237
44. Saran N.G., Pletcher M.T., Natale J.E., Cheng Y., and Reeves R.H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet. 12 (2003) 2013-2019
45. Smith D.J., Zhu Y., Zhang J., Cheng J.F., and Rubin E.M. Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2. Genomics 27 (1995) 425-434
46. Smith D.J., Stevens M.E., Sudanagunta S.P., Bronson R.T., Makhinson M., Watabe A.M., O'Dell T.J., Fung J., Weier H.U., Cheng J.F., and Rubin E.M. Functional screening of 2 Mb of human chromosome 21q22. 2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nature Genet. 16 (1997) 28-36
47. Schneider C., Risser D., Kirchner L., Kitzmuller E., Cairns N., Prast H., Singewald N., and Lubec G. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Neurosci. Lett. 222 (1997) 183-186
48. Sultan M., Piccini I., Balzereit D., Herwig R., Saran N.G., Lehrach H., Reeves R.H., and Yaspo M.L. Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol. 8 (2007) R91
49. Teipel S.J., and Hampel H. Neuroanaotmy of Down syndrome in vivo: a model of preclinical Alzheier's disease. Behav. Genet. 36 (2006) 405-415
50. Teipel S.J., Schapiro M.B., Alexander G.E., Krasuski J.S., Horwitz B., Hoehne C., Moller H.J., Rapoport S.I., and Hampel H. Relation of corpus callosum and hippocampal size to age in non-demented adults with Down's syndrome. Am. J. Psychiatry 160 (2003) 1870-1878
51. Wang P.P., Doherty S., Hesselink J.R., and Bellugi U. Callosal morphology concurs with neurobehavioral and neuropathological findings in two neurodevelopmental disorders. Arch. Neurol. 49 (1992) 407-411
52. Weis S., Weber G., Neuhold A., and Rett A. Down syndrome: MR quantification of brain structures and comparison with normal control subjects. Am. J. Neuroradiol. 12 (1991) 1207-1211
53. Wisniewski K.E. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. 7 (1990) 274-281
54. Wisniewski K.E., and Bobinski M. Hypothalamic abnormalities in Down syndrome. Prog. Clin. Biol. Res. 373 (1991) 153-167
55. Wisniewski K.E., and Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin. Neuropathol. 8 (1989) 55-62